The FDA cleared Ulthera, Inc.'s Ulthera System for the non-invasive treatment of the chest to improve lines and wrinkles of the décolleté.

The Ultherapy Décolletage Treatment uses the system's signature imaging and micro-focued ultrasound therapy capabilities. The treatment, which takes about 30 minutes to administer, stimulates the natural formation of collagen and elastin in the skin's foundation to gradually smooth chest wrinkles. Results are visible after about three months. As with the FDA-cleared Ultherapy procedure for lifting the neck, eyebrow, and under the chin, results are achieved with one treatment and with no downtime or post-treatment care requirements.

The Ultherapy Décolletage Treatment will be available in more than 1,500 physician practices in the US, beginning in the third quarter of this year.

“At my practice, there is a high patient demand for a safe and effective solution to treat the chest, but the only options available involved needles, multiple treatments, recovery time, and/or required restricted sun exposure,” said principal investigator Sabrina Fabi, MD of Cosmetic Laser Dermatology in San Diego. “Now, with the Ulterapy Décolletage Treatment, I can offer women and FDA-cleared solution that consistently works and can be done on their lunch hour, at any time of year, without downtime.”